Nomax Inc: Drug Recall
Recall #D-0462-2024 · 04/19/2024
Class II: Risk
Recall Details
- Recall Number
- D-0462-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Nomax Inc
- Status
- Ongoing
- Date Initiated
- 04/19/2024
- Location
- Saint Louis, MO, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,056 cartons
Reason for Recall
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Product Description
GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-003-40; b) 300 strips per carton, NDC 51801-003-50, Nomax, Inc., St. Louis, MO 63123.
Distribution Pattern
Nationwide in the USA
Other Recalls by Nomax Inc
- Class II: Risk 04/19/2024
- Class II: Risk 04/19/2024
- Class II: Risk 04/19/2024
- Class III: Low Risk 04/13/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.